The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 752K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for PJ Tummino


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.EBI
TBA
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase.EBI
Glaxosmithkline
 
6-Phenyl-6-alkylamido-5,6-dihydro-2H-pyran-2-ones: novel HIV protease inhibitorsEBI
TBA
 
Nonpeptidic HIV protease inhibitors: 3-(S-benzyl substituted)-4-hydroxy-6-(phenyl substituted)-2H-pyran-2-one with an inverse mode of bindingEBI
TBA
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.EBI
Johns Hopkins University
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.EBI
GlaxoSmithKline
Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1.EBI
GlaxoSmithKline
4-hydroxy-5,6-dihydro-2H-pyran-2-ones.3. Bicyclic and hetero-aromatic ring systems as 3-position scaffolds to bind to S1' and S2' of the HIV-1 protease enzyme.EBI
Warner-Lambert
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic properties.EBI
Warner-Lambert
Cannabinoid-2 agonistsBDB
Allergan
Small molecule myristate inhibitors of Bcr-abl and methods of useBDB
Dana-Farber Cancer Institute
Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitorBDB
East China University of Science and Technology
Inhibitors of PI3K-delta and methods of their use and manufactureBDB
Exelixis
Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disordersBDB
Janssen Pharmaceutica
BET bromodomain inhibitors and therapeutic methods using the sameBDB
University of Michigan
5-HT3 receptor antagonistsBDB
Takeda Pharmaceutical
Benzoxazinone derivatives for treatment of skin diseasesBDB
Sixera Pharma
Identification of potent and novel small-molecule inhibitors of caspase-3.BDB
Sunesis Pharmaceuticals
Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysis.BDB
Glaxosmithkline